Paper36915508
Apigenin-coated gold nanoparticles as a cardioprotective strategy against doxorubicin-induced cardiotoxicity in male rats via reducing apoptosis.
Sharifiaghdam Z and 4 others. Heliyon, 2023. Cited by 35 papers, by iCite.
Cite this record
ConductScience Library. Apigenin-coated gold nanoparticles as a cardioprotective strategy against doxorubicin-induced cardiotoxicity in male rats via reducing apoptosis. Papers, record 36915508. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36915508
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Apigenin-coated gold nanoparticles as a cardioprotective strategy against doxorubicin-induced cardiotoxicity in male rats via reducing apoptosis.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17143534 | Apigenin and cancer chemoprevention: progress, potential and promise (review). | Int J Oncol | 2007 | https://conductscience.org/library/papers/17143534 | PubMed |
| 2 | 24120900 | Efficacy of PLGA-loaded apigenin nanoparticles in Benzo[a]pyrene and ultraviolet-B induced skin cancer of mice: mitochondria mediated apoptotic signalling cascades. | Food Chem Toxicol | 2013 | https://conductscience.org/library/papers/24120900 | PubMed |
| 3 | 31625516 | Metal nanoparticles synthesis through natural phenolic acids. | IET Nanobiotechnol | 2019 | https://conductscience.org/library/papers/31625516 | PubMed |
| 4 | 26606860 | Baicalein alleviates doxorubicin-induced cardiotoxicity via suppression of myocardial oxidative stress and apoptosis in mice. | Life Sci | 2016 | https://conductscience.org/library/papers/26606860 | PubMed |
| 5 | 25243820 | Mitochondria as a target in the therapeutic properties of curcumin. | Arch Pharm (Weinheim) | 2014 | https://conductscience.org/library/papers/25243820 | PubMed |
| 6 | 28886513 | Construction of genetically engineered M13K07 helper phage for simultaneous phage display of gold binding peptide 1 and nuclear matrix protein 22 ScFv antibody. | Colloids Surf B Biointerfaces | 2017 | https://conductscience.org/library/papers/28886513 | PubMed |
| 7 | 26309539 | Apigenin attenuates acute myocardial infarction of rats via the inhibitions of matrix metalloprotease-9 and inflammatory reactions. | Int J Clin Exp Med | 2015 | https://conductscience.org/library/papers/26309539 | PubMed |
| 8 | 28185035 | Anthracycline Chemotherapy and Cardiotoxicity. | Cardiovasc Drugs Ther | 2017 | https://conductscience.org/library/papers/28185035 | PubMed |
| 9 | 23338126 | Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibition of the p38 MAPK pathway in H9c2 cells. | Int J Mol Med | 2013 | https://conductscience.org/library/papers/23338126 | PubMed |
| 10 | 24381528 | Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century. | Curr Neuropharmacol | 2013 | https://conductscience.org/library/papers/24381528 | PubMed |
| 11 | 9061039 | Doxorubicin-induced acute changes in cytotoxic aldehydes, antioxidant status and cardiac function in the rat. | Biochim Biophys Acta | 1997 | https://conductscience.org/library/papers/9061039 | PubMed |
| 12 | 29802937 | Apigenin loaded nanoparticle delayed development of hepatocellular carcinoma in rats. | Nanomedicine | 2018 | https://conductscience.org/library/papers/29802937 | PubMed |
| 13 | 28684964 | Apigenin Attenuates Adriamycin-Induced Cardiomyocyte Apoptosis via the PI3K/AKT/mTOR Pathway. | Evid Based Complement Alternat Med | 2017 | https://conductscience.org/library/papers/28684964 | PubMed |
| 14 | 26598943 | Breast cancer therapy-associated cardiovascular disease. | Nat Rev Clin Oncol | 2016 | https://conductscience.org/library/papers/26598943 | PubMed |
| 15 | 22763982 | Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in lymphoma nude mice by heme oxygenase-1 induction. | Cardiovasc Toxicol | 2012 | https://conductscience.org/library/papers/22763982 | PubMed |
| 16 | 25895646 | Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms. | Trends Pharmacol Sci | 2015 | https://conductscience.org/library/papers/25895646 | PubMed |
| 17 | 31279781 | Apigenin attenuates doxorubicin induced cardiotoxicity via reducing oxidative stress and apoptosis in male rats. | Life Sci | 2019 | https://conductscience.org/library/papers/31279781 | PubMed |
| 18 | 36071293 | Folate functionalized gold-coated magnetic nanoparticles effect in combined electroporation and radiation treatment of HPV-positive oropharyngeal cancer. | Med Oncol | 2022 | https://conductscience.org/library/papers/36071293 | PubMed |
| 19 | 27297631 | Crocin treatment prevents doxorubicin-induced cardiotoxicity in rats. | Life Sci | 2016 | https://conductscience.org/library/papers/27297631 | PubMed |
| 20 | 20413894 | PPARgamma agonist curcumin reduces the amyloid-beta-stimulated inflammatory responses in primary astrocytes. | J Alzheimers Dis | 2010 | https://conductscience.org/library/papers/20413894 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42123793 | Comparison of Selected Pro-Health Biologically Active Chemical Compounds in Salviae herba from Selected Species. | Molecules | 2026 | https://conductscience.org/library/papers/42123793 | PubMed |
| 41640995 | Salvia coccinea and Apigenin: A Natural Treasure of Lamiaceae in Pharmacological Innovation. | Food Sci Nutr | 2026 | https://conductscience.org/library/papers/41640995 | PubMed |
| 41284073 | The role of nitric oxide and connexin 43 in the cardioprotective effects of apigenin against doxorubicin-induced cardiotoxicity in male rats. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/41284073 | PubMed |
| 41177867 | Apigenin regulates CCR5/JAK1/STAT1/MMPs signaling to alleviate secondary brain injury after intracerebral hemorrhage and its enhanced delivery via targeted nanoparticles. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/41177867 | PubMed |
| 40640696 | Therapeutic potential of gold nanoparticles in cancer therapy: a comparative insight into synthesis overview and cellular mechanisms. | Med Oncol | 2025 | https://conductscience.org/library/papers/40640696 | PubMed |
| 40631045 | CLINICALLY RELEVANT METALLIC NANOPARTICLES IN TUBERCULOSIS DIAGNOSIS AND THERAPY. | Adv Ther (Weinh) | 2025 | https://conductscience.org/library/papers/40631045 | PubMed |
| 40366401 | Toxicological and anti-inflammatory activities of doxorubicin loaded onto pH-sensitive poly(β-amino ester) modified mesoporous silica nanoparticles in mice. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/40366401 | PubMed |
| 40005990 | Aggregation-Caused Quenching Dyes as Potent Tools to Track the Integrity of Antitumor Nanocarriers: A Mini-Review. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40005990 | PubMed |
| 39598480 | Potential Protective Effect of Orlistat: A Formulation of Nanocrystals Targeting Inflammation, Oxidative Stress, and Apoptosis in an Experimental Model of Doxorubicin-Induced Cardiotoxicity. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39598480 | PubMed |
| 39259258 | Enhancing therapy with nano-based delivery systems: exploring the bioactive properties and effects of apigenin. | Ther Deliv | 2024 | https://conductscience.org/library/papers/39259258 | PubMed |
| 38935128 | Biogenic metallic nanoparticles: from green synthesis to clinical translation. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | https://conductscience.org/library/papers/38935128 | PubMed |
| 38927560 | Apigenin: A Bioflavonoid with a Promising Role in Disease Prevention and Treatment. | Biomedicines | 2024 | https://conductscience.org/library/papers/38927560 | PubMed |
| 38817429 | Tackling breast cancer with gold nanoparticles: twinning synthesis and particle engineering with efficacy. | Nanoscale Adv | 2024 | https://conductscience.org/library/papers/38817429 | PubMed |
| 38399309 | Review of Advances in Coating and Functionalization of Gold Nanoparticles: From Theory to Biomedical Application. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/38399309 | PubMed |
| 37928261 | Screening of an FDA-approved compound library identifies apigenin for the treatment of myocardial injury. | Int J Biol Sci | 2023 | https://conductscience.org/library/papers/37928261 | PubMed |
| 37083267 | Radiosensitising effect of iron oxide-gold nanocomplex for electron beam therapy of melanoma in vivo by magnetic targeting. | IET Nanobiotechnol | 2023 | https://conductscience.org/library/papers/37083267 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36915508
GET https://conductscience.org/api/papers/v1/36915508/references?page=2